Therapeutic Lipidology / edited by Michael H. Davidson, Peter P. Toth, Kevin C. Maki.

Chapter 1. History of Lipidology -- Chapter 2. Atherogenesis and Vascular Biology -- Chapter 3. Genetic Disorders of Lipoprotein Metabolism -- Chapter 4. Cardiovascular Genomics -- Chapter 5. Epidemiology of Atherosclerotic Cardiovascular Disease -- Chapter 6. Comparison of 2018 AHA-ACC Multi-Society Cholesterol Guidelines with 2013 ACC-AHA Cholesterol Guidelines -- Chapter 7. The Low-Density Lipoprotein Cholesterol Hypothesis: An Update -- Chapter 8. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk -- Chapter 9. Medical Nutrition Therapy for Lipid and Lipoprotein Disorders -- Chapter 10. Nutraceuticals and Lipid Management -- Chapter 11. Pharmacology of Statins -- Chapter 12. Management of Statin Intolerance -- Chapter 13. Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins and Plant Sterols -- Chapter 14. Proprotein Convertase Subtilisin/Kexin Type 9: Functional Role in Lipid Metabolism and its Therapeutic Inhibition -- Chapter 15. Management of Hypertriglyceridemia (Including Fibrates and n-3 Fatty Acids) -- Chapter 16. Pathophysiology and Management of Dyslipidemias Associated with Insulin-resistant States -- Chapter 17. Therapeutic Management of Obesity -- Chapter 18. High Density Lipoproteins -- Chapter 19. Lipoprotein (a): Principles from Bench to Bedside -- Chapter 20. Management of Homozygous Familial Hypercholesterolemia -- Chapter 21. Lysosomal Acid Lipase Deficiency -- Chapter 22. Lipodystrophies -- Chapter 23. HIV and Dyslipidemia -- Chapter 24. Cardiovascular Disease in Women: Focus on Lipid Management -- Chapter 25. Management of Dyslipidemia in the Elderly -- Chapter 26. Management of Dyslipidemia in Children -- Chapter 27. Lipoprotein Subfractions in Clinical Practice -- Chapter 28. Ion Mobility Lipoprotein Analysis -- Chapter 29. How ApoB Measurements Could Improve Prevention of Cardiovascular Disease -- Chapter 30. C-reactive Protein and Other Inflammatory Markers in Cardiovascular Disease; Inflammatory Disorders and Atherosclerosis -- Chapter 31. Coronary Artery Calcium and CT Angiography -- Chapter 32. The Clinical Use of Ultrasound for Atherosclerosis Imaging -- Chapter 33. Emerging Therapies for Regulating Dyslipidemias and Atherosclerosis -- Chapter 34. The Allied Health Professional's Role in the Management of Dyslipidemia and Accreditation Council for Clinical Lipidology Certification Program -- Chapter 35. The American Board of Clinical Lipidology Physician Certification Program.